Transition Therapeutics Stock Price, News & Analysis (TSE:TTH)

Previous CloseN/A
Today's RangeN/A
52-Week RangeC$0.89 - C$3.54
VolumeN/A
Average Volume2,031 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Transition Therapeutics (TSE:TTH)

Transition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents. The Company is developing therapeutics for central nervous system (CNS) and metabolic disease indications. The Company's technologies are focused on the treatment of agitation and aggression in Alzheimer's disease and diabetes. The Company's subsidiary, Transition Therapeutics Ireland Limited (Transition Ireland), is developing two drug candidates: neuropsychiatric candidate ELND005 and androgen deficiency candidate TT701. The Company's subsidiary, Waratah Pharmaceuticals Inc. (Waratah), is developing diabetes drug candidate TT401. The Company's other two entities provide development services in support of the clinical and non-clinical activities of Transition Ireland and Waratah.

Receive TTH News and Ratings via Email

Sign-up to receive the latest news and ratings for TTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:TTH
CUSIPN/A
Phone+1-416-2607770

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($1.39)
Net IncomeN/A
Net MarginsN/A
Return on Equity-58.00%
Return on Assets-47.29%

Miscellaneous

EmployeesN/A
Outstanding Shares38,800,000

Transition Therapeutics (TSE:TTH) Frequently Asked Questions

What is Transition Therapeutics' stock symbol?

Transition Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TTH."

Who are some of Transition Therapeutics' key competitors?

How do I buy Transition Therapeutics stock?

Shares of Transition Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How can I contact Transition Therapeutics?

Transition Therapeutics' mailing address is 101 College St Suite 220, TORONTO, ON M5G 1L7, Canada. The biopharmaceutical company can be reached via phone at +1-416-2607770.


MarketBeat Community Rating for Transition Therapeutics (TTH)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about Transition Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Transition Therapeutics (TSE:TTH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Transition Therapeutics (TSE:TTH) Consensus Price Target History

Price Target History for Transition Therapeutics (TSE:TTH)

Transition Therapeutics (TSE:TTH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/10/2016Canaccord GenuityLower Price TargetHoldC$2.00 -> C$1.50View Rating Details
(Data available from 1/19/2016 forward)

Earnings

Transition Therapeutics (TSE:TTH) Earnings History and Estimates Chart

Earnings by Quarter for Transition Therapeutics (TSE:TTH)

Transition Therapeutics (TSE TTH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2016Q3 2016C($0.11)ViewN/AView Earnings Details
2/9/2016Q2 2016C($0.05)ViewN/AView Earnings Details
11/10/2015Q1 2016C($0.12)ViewN/AView Earnings Details
9/15/2015Q4 2015C($0.38)ViewN/AView Earnings Details
5/12/2015Q3 2015C($0.13)ViewN/AView Earnings Details
2/9/2015Q2 2015C($0.48)ViewN/AView Earnings Details
11/12/2014Q1 2015C($0.45)ViewN/AView Earnings Details
9/25/2014Q4 2014C($0.43)ViewN/AView Earnings Details
5/13/2014Q3 2014C($0.17)ViewN/AView Earnings Details
2/12/2014Q2 2014C($0.04)ViewN/AView Earnings Details
11/12/2013Q1C($0.08)ViewListenView Earnings Details
9/11/2013Q4 2013C$0.16ViewN/AView Earnings Details
5/7/2013Q3 2013C($0.11)ViewN/AView Earnings Details
2/7/2013Q2 2013C($0.11)C($0.10)ViewN/AView Earnings Details
11/8/2012Q1 2013C$0.29ViewN/AView Earnings Details
9/13/2012Q4 2012C($0.09)ViewN/AView Earnings Details
5/8/2012Q3 2012C($0.13)C($0.11)ViewN/AView Earnings Details
2/9/2012Q2 2012C($0.12)C($0.15)ViewN/AView Earnings Details
12/1/2011Q1 2012C($0.15)C($0.12)ViewN/AView Earnings Details
9/19/2011Q4 2011C($0.13)C($0.17)ViewN/AView Earnings Details
5/10/2011Q3 2011C($0.18)C($0.13)ViewN/AView Earnings Details
2/7/2011Q2 2011C$1.10C$1.05ViewN/AView Earnings Details
11/11/2010Q1 2011C($0.20)C($0.19)ViewN/AView Earnings Details
9/27/2010Q4 2010C($0.22)C($0.19)ViewN/AView Earnings Details
5/10/2010Q3 2010C($0.11)C($0.13)ViewN/AView Earnings Details
2/10/2010Q2 2010C($0.19)C($0.26)ViewN/AView Earnings Details
11/10/2009Q1 2010C($0.22)C($0.24)ViewN/AView Earnings Details
5/13/2009Q3 2009C($0.25)ViewN/AView Earnings Details
2/11/2009Q2 2009C($0.21)ViewN/AView Earnings Details
11/10/2008Q1 2009C($0.22)ViewN/AView Earnings Details
5/14/2008Q3 2008C($0.22)ViewN/AView Earnings Details
2/12/2008Q2 2008C($0.07)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Transition Therapeutics (TSE:TTH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Transition Therapeutics (TSE:TTH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Transition Therapeutics (TSE TTH) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Transition Therapeutics (TSE:TTH)

Transition Therapeutics (TSE TTH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2015Norla Nicole RusawInsiderBuy1,000C$0.00C$0.00
(Data available from 1/1/2013 forward)

Headlines

Transition Therapeutics (TSE TTH) News Headlines

Source:
DateHeadline
Form 8-K BRAINSTORM CELL THERAPEU For: Jan 03 - StreetInsider.comForm 8-K BRAINSTORM CELL THERAPEU For: Jan 03 - StreetInsider.com
www.streetinsider.com - January 4 at 4:12 PM
SORRENTO THERAPEUTICS, INC. - StreetInsider.comSORRENTO THERAPEUTICS, INC. - StreetInsider.com
www.streetinsider.com - December 20 at 4:11 PM
Form 8-K AMICUS THERAPEUTICS INC For: Dec 14 - StreetInsider.comForm 8-K AMICUS THERAPEUTICS INC For: Dec 14 - StreetInsider.com
www.streetinsider.com - December 14 at 10:59 AM
Form 8-K ACORDA THERAPEUTICS INC For: Nov 20 - StreetInsider.comForm 8-K ACORDA THERAPEUTICS INC For: Nov 20 - StreetInsider.com
www.streetinsider.com - November 22 at 1:38 PM
Form 8-K Jounce Therapeutics, For: Oct 20 - StreetInsider.comForm 8-K Jounce Therapeutics, For: Oct 20 - StreetInsider.com
www.streetinsider.com - October 23 at 3:31 PM
SERES THERAPEUTICS, INC. - StreetInsider.comSERES THERAPEUTICS, INC. - StreetInsider.com
www.streetinsider.com - October 17 at 8:21 AM
Form 8-K Acer Therapeutics Inc. For: Oct 02 - StreetInsider.comForm 8-K Acer Therapeutics Inc. For: Oct 02 - StreetInsider.com
www.streetinsider.com - October 7 at 9:23 AM
Form 8-K SOLENO THERAPEUTICS INC For: Oct 06 - StreetInsider.comForm 8-K SOLENO THERAPEUTICS INC For: Oct 06 - StreetInsider.com
www.streetinsider.com - October 7 at 9:23 AM
Form 8-K Celldex Therapeutics, For: Oct 03 - StreetInsider.comForm 8-K Celldex Therapeutics, For: Oct 03 - StreetInsider.com
www.streetinsider.com - October 3 at 1:55 PM
Form 8-K Neos Therapeutics, Inc. For: Oct 02 - StreetInsider.comForm 8-K Neos Therapeutics, Inc. For: Oct 02 - StreetInsider.com
www.streetinsider.com - October 3 at 1:55 PM
Form 8-K Ocera Therapeutics, Inc. For: Sep 28 - StreetInsider.comForm 8-K Ocera Therapeutics, Inc. For: Sep 28 - StreetInsider.com
www.streetinsider.com - September 30 at 2:47 PM
Audentes Therapeutics, Inc. - StreetInsider.comAudentes Therapeutics, Inc. - StreetInsider.com
www.streetinsider.com - September 28 at 7:36 AM
Form 8-K Acer Therapeutics Inc. For: Sep 26 - StreetInsider.comForm 8-K Acer Therapeutics Inc. For: Sep 26 - StreetInsider.com
www.streetinsider.com - September 28 at 7:36 AM
Form 8-K ARGOS THERAPEUTICS INC For: Sep 26 - StreetInsider.comForm 8-K ARGOS THERAPEUTICS INC For: Sep 26 - StreetInsider.com
www.streetinsider.com - September 28 at 7:36 AM
DIMENSION THERAPEUTICS, INC. - StreetInsider.comDIMENSION THERAPEUTICS, INC. - StreetInsider.com
www.streetinsider.com - September 19 at 8:50 AM
Form 8-K AMICUS THERAPEUTICS INC For: Sep 19 - StreetInsider.comForm 8-K AMICUS THERAPEUTICS INC For: Sep 19 - StreetInsider.com
www.streetinsider.com - September 19 at 8:50 AM
Mirna Therapeutics, Inc. - StreetInsider.comMirna Therapeutics, Inc. - StreetInsider.com
www.streetinsider.com - August 27 at 7:42 AM
Form 8-K PROTEON THERAPEUTICS For: Aug 17 - StreetInsider.comForm 8-K PROTEON THERAPEUTICS For: Aug 17 - StreetInsider.com
www.streetinsider.com - August 23 at 1:02 PM
Form 8-K Onconova Therapeutics, For: Aug 15 - StreetInsider.comForm 8-K Onconova Therapeutics, For: Aug 15 - StreetInsider.com
www.streetinsider.com - August 17 at 8:40 AM
OVID THERAPEUTICS INC. - StreetInsider.comOVID THERAPEUTICS INC. - StreetInsider.com
www.streetinsider.com - August 17 at 8:40 AM
Form 8-K AMICUS THERAPEUTICS INC For: Aug 07 - StreetInsider.comForm 8-K AMICUS THERAPEUTICS INC For: Aug 07 - StreetInsider.com
www.streetinsider.com - August 9 at 8:31 AM
Form 8-K Bellerophon Therapeutics For: Aug 03 - StreetInsider.comForm 8-K Bellerophon Therapeutics For: Aug 03 - StreetInsider.com
www.streetinsider.com - August 4 at 9:21 AM
Form 8-K NOVELION THERAPEUTICS For: Jul 31 - StreetInsider.comForm 8-K NOVELION THERAPEUTICS For: Jul 31 - StreetInsider.com
www.streetinsider.com - August 4 at 9:21 AM
OBALON THERAPEUTICS, INC. - StreetInsider.comOBALON THERAPEUTICS, INC. - StreetInsider.com
www.streetinsider.com - August 4 at 9:21 AM
PTC Therapeutics Announces Publication of Data from ACT DMD in The Lancet - PR Newswire (press release)PTC Therapeutics Announces Publication of Data from ACT DMD in The Lancet - PR Newswire (press release)
www.prnewswire.com - July 19 at 8:35 AM
Form 8-K Opexa Therapeutics, Inc. For: Jul 18 - StreetInsider.comForm 8-K Opexa Therapeutics, Inc. For: Jul 18 - StreetInsider.com
www.streetinsider.com - July 19 at 8:35 AM
Viking Therapeutics, Inc. - StreetInsider.comViking Therapeutics, Inc. - StreetInsider.com
www.streetinsider.com - July 6 at 7:46 PM
Form 8-K ACORDA THERAPEUTICS INC For: Jun 29 - StreetInsider.comForm 8-K ACORDA THERAPEUTICS INC For: Jun 29 - StreetInsider.com
www.streetinsider.com - July 1 at 8:32 AM
Form 8-K Neos Therapeutics, Inc. For: Jun 26 - StreetInsider.comForm 8-K Neos Therapeutics, Inc. For: Jun 26 - StreetInsider.com
www.streetinsider.com - June 27 at 9:24 AM
Form 8-K TG THERAPEUTICS, INC. For: Jun 16 - StreetInsider.comForm 8-K TG THERAPEUTICS, INC. For: Jun 16 - StreetInsider.com
www.streetinsider.com - June 22 at 7:20 PM
Form 8-K Neos Therapeutics, Inc. For: Jun 19 - StreetInsider.comForm 8-K Neos Therapeutics, Inc. For: Jun 19 - StreetInsider.com
www.streetinsider.com - June 22 at 2:18 PM
APTEVO THERAPEUTICS INC. - StreetInsider.comAPTEVO THERAPEUTICS INC. - StreetInsider.com
www.streetinsider.com - June 22 at 2:18 PM
Form 8-K PLURISTEM THERAPEUTICS For: May 25 - StreetInsider.comForm 8-K PLURISTEM THERAPEUTICS For: May 25 - StreetInsider.com
www.streetinsider.com - May 27 at 6:26 AM
Form 8-K AMICUS THERAPEUTICS INC For: May 22 - StreetInsider.comForm 8-K AMICUS THERAPEUTICS INC For: May 22 - StreetInsider.com
www.streetinsider.com - May 24 at 8:39 AM
Form 8-K Opexa Therapeutics, Inc. For: May 22 - StreetInsider.comForm 8-K Opexa Therapeutics, Inc. For: May 22 - StreetInsider.com
www.streetinsider.com - May 24 at 8:39 AM
Transition Therapeutics Announces Special...Transition Therapeutics Announces Special...
www.benzinga.com - August 26 at 10:49 AM
Transition Therapeutics Announces Special Shareholder Meeting Voting Results ...Transition Therapeutics Announces Special Shareholder Meeting Voting Results ...
www.marketwatch.com - August 26 at 10:49 AM
OPKO Healths Latest Acquisition A WinnerOPKO Health's Latest Acquisition A Winner
www.forbes.com - August 10 at 8:36 PM
Q3 2016 Transition Therapeutics Inc Earnings Release - After Market CloseQ3 2016 Transition Therapeutics Inc Earnings Release - After Market Close
biz.yahoo.com - May 11 at 7:07 AM
Q2 2016 Transition Therapeutics Inc Earnings Release - After Market CloseQ2 2016 Transition Therapeutics Inc Earnings Release - After Market Close
biz.yahoo.com - February 9 at 7:07 AM
Q1 2016 Transition Therapeutics Inc Earnings Release - After Market CloseQ1 2016 Transition Therapeutics Inc Earnings Release - After Market Close
biz.yahoo.com - November 10 at 7:07 AM

SEC Filings

Transition Therapeutics (TSE:TTH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Transition Therapeutics (TSE TTH) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.